Day 1 :
Keynote Forum
Kenneth Lu
University of California Los Angeles, USA
Keynote: Using pattern ERG to objectively measure contrast sensitivity associated with intraocular lenses
Time : 09:30-10:15
Biography:
Kenneth Lu is an Assistant Professor of Ophthalmology at Doheny Eye Institute, University of California, Los Angeles, specializing in Cataract and Refractive Surgery. He has a special interest in the new technology IOLs. He holds a patent on the Ojo accommodating IOL and is the founder of the annual Innovations and Entrepreneurship: Ideation to Commercialization Conference at Doheny Eye Institute. He is also an investor as well as an entrepreneur/innovator. His research area ranges from electrophysiology, glaucoma to refractive cataract surgery.
Abstract:
Statement of the Problem: Multifocal intraocular lenses provide distance and near vision without spectacle correction but
often at the cost of loss of contrast sensitivity. Previous testing for contrast sensitivity utilizes subjective response from patients
and is difficult to quantify.
Purpose: To use pattern electroretinogram (pERG) to quantify contrast sensitivity (CS) with monofocal vs. multifocal intraocular lenses (IOLs).
Methods: Pattern ERG was performed on 5 healthy eyes of 5 patients through an extra-ocular lens apparatus that directed the image through no IOL (control), plano trial lenses, monofocal IOL, and multifocal IOL. Stimulus image was kept constant at a 20/200 level, while contrast was progressively decreased from 100% to 95%, 90%, 85%, 80% and 75%.
Results: The response curve was statistically lower in plano vs. no lens (p=0.0001), demonstrating that any lens in the system
served to block some light from entering the eye; in multifocal IOL vs. plano, (p=0.0000) as well as in multifocal IOL vs.
monofocal IOL (p=0.0005), demonstrating that multifocal IOL decreased contrast sensitivity compared to monofocal IOL and
plano-lenses. The decrease was in between 25% to 45%. The response curves were not statistically different between monofocal
IOL and plano (p=0.5064), demonstrating monofocal IOLs did not reduce contrast sensitivity as compared to plano set up.
Conclusion: Multifocal IOL decreased perception of contrast in patients more than monofocal IOL. For the first time, we have
objective measurements to quantify the loss of contrast sensitivity.
Keynote Forum
Sanjoy Chowdhury
Bokaro General Hospital, India
Keynote: Secondary glaucoma in uveitis: Can incidence be reduced?
Time : 10:15-10:45
Biography:
Sanjoy Chowdhury is an honors graduate of Calcutta Medical college (MBBS: 1987), who trained in Ophthalmology at the university of Aligarh, receiving postgraduate “diploma “with university Gold Medal (DO:1990) and at the University of Delhi, India to bag the Master’s degree (MS:1993). He is a “Diplomat of National Board of Examinations (1992)” and is a very experienced micro surgeon with special interest in Squint and Community Ophthalmology mainly Leprosy & eye injury. Beyond Eye: Jawhar award, best Innovative manager in 2011 and 2013 of Bokaro steel /SAIL& Best male speaker of AISMOC (SAIL/Bokaro), Joint Director (Medical & health services, SAIL/Bokaro). Head of ophthalmology department, Bokaro general hospital (ISO certified multispecialty 910 bedded hospital).
Abstract:
Background: Secondary Glaucoma, due to disease or drugs is common in uveitis.
Purpose: To evaluate prevalence of secondary glaucoma (SG) in uveitis with different treatment regimen.
Methods: Randomised prospective hospital based study of uveitis from 2007-2012. Baseline IOP, Field and optic nerve head
photographs were recorded. Three groups were randomised: (1) topical steroid, (2) Systemic steroid+gr-1 and (3) Topical
synthetic steroids, cycloplegic and periorbital triamcinolone injection. IOP more than 22 mm/4mm increase from baseline is
marker.
Results: 1254 uveitis cases, prevalence rate 63/100000 and 82 SG, 70% in anterior uveitis. During treatment, SG was maximum
(80%) in first group and least (5%) with synthetic steroid combined with periorbital triamcinolone. Multi variate analysis
shows synthetic steroid and periorbital triamcinolone has least association with SG.
Conclusion: SG is an underappreciated visual threat in uveitis which can be modulated effectively with newer steroids.